Reaction

Lower Respiratory Tract Infection Fungal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 388 reports · 21 co-occurring drugs

As of the last recalculation, Lower Respiratory Tract Infection Fungal appears in 388 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE INJECTION (PRR 74.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Voriconazole Injection2874.574.6
Posaconazole2173.273.3
Itraconazole1571.671.7
Posaconazole Delayed-Release1365.765.7
Voriconazole3057.357.4
Amphotericin B1253.053.0
Thiotepa951.751.8
Cytarabine4747.647.6
Vincristine Sulfate2446.846.8
Busulfan1345.845.9
Pegaspargase940.340.4
Ganciclovir737.337.4
Ganciclovir Sodium736.136.1
Mercaptopurine1135.035.0
Blinatumomab526.026.0
Etoposide3124.524.5
Azacitidine For721.021.0
Azacitidine1120.420.4
Lumacaftor And Ivacaftor318.918.9
Dornase Alfa616.716.7
Axicabtagene Ciloleucel316.416.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.